Min, K. I., Kwag, D., Min, G. J., Park, S., Park, S., Lee, S., Cho, B., Eom, K., Kim, Y., Kim, H., Min, C., Cho, S., Yoon, J. (2025). MRD-guided outcome analysis of ponatinib plus hyper-CVAD versus historical imatinib in ph-positive ALL: Impact of early response and dose-adjusted ponatinib. Blood. https://doi.org/10.1182/blood-2025-3327